Portfolio (Quarterly)
Guide ↗
Krensavage Asset Management, LLC
· CIK 0001609251| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 2,866,138.0 | $41.8M | 15.88% | NEW | — | $14.58 | -16.9% |
| 2 | JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | 167,816.0 | $40.4M | 15.36% | NEW | — | $240.97 | +0.2% |
| 3 | UTHR | UNITED THERAPEUTICS CORP | Healthcare | 69,282.0 | $37.5M | 14.26% | NEW | — | $541.83 | -9.0% |
| 4 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 524,786.0 | $30.0M | 11.41% | NEW | — | $57.22 | +12.0% |
| 5 | EXEL | EXELIXIS INC | Healthcare | 370,693.0 | $20.2M | 7.66% | NEW | — | $54.41 | +5.2% |
| 6 | ABT | ABBOTT LABORATORIES | Healthcare | 200,000.0 | $18.1M | 6.89% | NEW | — | $90.74 | +13.5% |
| 7 | SNY | SANOFI-ADR | Healthcare | 323,946.0 | $13.8M | 5.25% | NEW | — | $42.66 | -0.4% |
| 8 | SUPN | SUPERNUS PHARMACEUTICALS INC | Healthcare | 280,681.0 | $13.1M | 4.96% | NEW | — | $46.51 | -8.0% |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 390,879.0 | $13.1M | 4.96% | NEW | — | $33.39 | -56.1% |
| 10 | VNDA | VANDA PHARMACEUTICALS INC | Healthcare | 1,180,388.0 | $7.2M | 2.74% | NEW | — | $6.12 | -15.8% |
| 11 | BNTX | BIONTECH SE-ADR | Healthcare | 59,523.0 | $5.5M | 2.10% | NEW | — | $93.06 | +5.3% |
| 12 | GSK | GSK PLC-SPON ADR | Healthcare | 96,729.0 | $5.1M | 1.93% | NEW | — | $52.42 | -2.6% |
| 13 | BIIB | BIOGEN INC | Healthcare | 20,000.0 | $4.3M | 1.64% | NEW | — | $216.05 | +1.4% |
| 14 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 6,000.0 | $3.7M | 1.42% | NEW | — | $623.50 | +28.0% |
| 15 | EMBC | EMBECTA CORP | Healthcare | 1,135,340.0 | $3.7M | 1.41% | NEW | — | $3.26 | +62.6% |
| 16 | ARDX | ARDELYX INC | Healthcare | 534,523.0 | $2.7M | 1.04% | NEW | — | $5.10 | -31.4% |
| 17 | INMD | INMODE LTD | Healthcare | 120,942.0 | $1.8M | 0.67% | NEW | — | $14.62 | -0.8% |
| 18 | EOLS | EVOLUS INC | Healthcare | 157,985.0 | $1.1M | 0.42% | NEW | — | $6.94 | +15.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%